4.4 Review

Pharmacokinetics and Target Attainment of ss-lactam Antibiotics in Older People: A Systematic Review of Current Literature

Journal

CLINICAL PHARMACOKINETICS
Volume 62, Issue 1, Pages 1-43

Publisher

ADIS INT LTD
DOI: 10.1007/s40262-022-01196-1

Keywords

-

Ask authors/readers for more resources

This systematic review examines the pharmacokinetics and target attainment of ss-lactam antibiotics in older people, highlighting the need for dose optimization in this patient population. The study reveals decreased clearance and prolonged elimination half-life in aged subjects compared to young subjects, with renal function being a critical factor. It emphasizes the importance of model-based PK studies that consider both physiological and disease-related changes.
Background and objective (Patho)physiological changes in older people may influence the pharmacokinetics (PK), and consequently the target attainment, of ss-lactam antibiotics using standard dosing regimens. This systematic review compiles the current knowledge on the PK and target attainment of ss-lactam antibiotics in older people, with the aim to identify priorities for dose optimization in this patient population.Methods A systematic literature search of the PubMed and EMBASE databases was conducted. Relevant articles published prior to 1 December 2021 were identified as eligible when they included data on the PK of ss-lactam antibiotics in adults >= 65 years of age. Extracted information included reported PK parameters (volume of distribution, clearance [CL], elimination rate constant, intercompartmental CL, elimination half-life, area under the concentration-time curve, maximum and trough concentration), covariates on PK parameters, target attainment rate, and dosing recommendations. Results Ninety-one relevant articles were included in this review. Four main ss-lactam subclasses were represented: 59.3% on cephalosporins + cephamycins, 25.3% on penicillins, 15.4% on carbapenems, and 3.3% on monobactams; 65.9% of articles involved intravenous administration, 16.5% mixed administration routes, 12.1% oral administration, and 5.5% intramuscular administration. The majority of studies had a small sample size, often did not include detailed information on the study population and methods, and were fairly old. CL was, on average, decreased, while elimination half-life was prolonged in aged subjects compared with young subjects. Volume of distribution was generally similar between age groups. Most studies identified renal function as the most important contributor to altered drug CL. In only 30.8% of the articles, target attainment was studied, and in 35.7% of these articles, target attainment was found to be suboptimal. Dosing recommendations were incorporated in 87.9% of articles.Conclusion Studies frequently fail to provide an evidence-based dosing recommendation for this diverse patient population. Model-based PK studies that address both physiological and disease-related changes are urgently needed. This review identified gaps of knowledge to set priorities for further research.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available